The Karmanos Cancer Institute employs a range of advanced technologies and methodologies to enhance cancer care and research. As a National Cancer Institute-designated comprehensive cancer center, Karmanos offers access to over 250 innovative cancer-specific treatments, many of which are not available elsewhere. The institute emphasizes the importance of early detection and provides a robust Screening and Prevention Program to identify cancers in their initial stages, thereby improving treatment outcomes. Additionally, Karmanos conducts more than 300 clinical trials annually, allowing patients to participate in cutting-edge research that may lead to new therapies and treatment options.

In terms of research capabilities, Karmanos Cancer Institute is equipped with various core facilities that support a wide array of scientific investigations. These include biostatistics and bioinformatics, molecular imaging, and pharmacology cores, which facilitate the development and evaluation of new cancer therapies. The institute also collaborates with Wayne State University and other partners to drive research initiatives, focusing on areas such as tumor biology, molecular therapeutics, and health disparities. This collaborative approach not only enhances the quality of cancer care provided but also contributes to the advancement of cancer research, ultimately aiming to improve patient outcomes and survivorship.

United States

Karmanos Cancer Institute is a healthcare organization specializing in cancer treatment, medical services, and oncology research.

Karmanos Cancer Institute

Company Details